New Zealand markets open in 4 hours 6 minutes

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
172.43+12.87 (+8.07%)
As of 01:54PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close159.56
Bid172.05 x 1200
Ask172.14 x 1100
Day's range159.41 - 173.66
52-week range115.61 - 497.49
Avg. volume5,900,183
Market cap68.586B
Beta (5Y monthly)1.65
PE ratio (TTM)4.76
EPS (TTM)36.21
Earnings date03 Aug 2022 - 08 Aug 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est219.33
  • Editor's pick
    Yahoo Finance Video

    The timeline of the FDA's ban on Juul vaping products

    Yahoo Finance health reporter Anjalee Khemlani outlines the events surrounding the FDA's ban on Juul products and e-cigarettes, as well as Pfizer's Paxlovid COVID-19 treatment pill receiving an Emergency Use Authorization from the FDA.

  • Motley Fool

    Why Moderna Stock Is Surging Today

    What happened Shares of Moderna (NASDAQ: MRNA) were trading 6.9% higher as of 11:07 a.m. ET on Thursday, though the company hadn't announced any new developments. Instead, those gains appear to be primarily the result of a broader stock market bounce.

  • Motley Fool

    Is Moderna Stock a No-Brainer Buy With Omicron Boosters on the Way?

    This should be especially good news for Moderna (NASDAQ: MRNA). The first hurdle is that Moderna must obtain FDA Emergency Use Authorization (EUA) for its omicron booster. The second hurdle for Moderna is to secure an additional supply deal with the U.S. government that includes omicron boosters.